DALLAS, Sept. 8, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug-free patch therapies maker BioElectronics Corp. (Pink Sheets:BIEL). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The investment report on BioElectronics Corp. (Pink Sheets:BIEL) should be of particular interest to other medical device companies: I-Flow Corp. (Nasdaq:IFLO), NeuroMetrix Inc. (Nasdaq:NURO), AngioDynamics Inc. (Nasdaq:ANGO) and Accuray Inc. (Nasdaq:ARAY).
It is available at: http://www.stockpreacher.com/n/BIEL
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher
BioElectronics Corp. (BIEL) engages in the development of revolutionary drug-free therapeutic devices for a variety of medical conditions. Its family of inexpensive, disposable drug-free anti-inflammatory products are made under the names ActiPatch(tm) Therapy, RecoveryRx(tm) Devices, HealFast(tm) Therapy and Allay(tm). The Company's first product, ActiPatch(tm) Therapy, is a dermal patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy. ActiPatch addresses pain and inflammation associated with medical surgeries, chronic wounds, oral surgeries, sprains, strains, lower back pain, as well as chronic repetitive stress injuries.
In the report, the analyst notes:
"Moving forward in the heel and foot pain treatment market, the Company recently announced the completion of a clinical study which shows significant results. As stated by BIEL CEO Andrew Whelan, the data showed that study participants were able to reduce the amount of pain medication when using ActiPatch therapy. Whelan added that the Company will be using the data to support its upcoming pre-marketing submission to the FDA. If approved, BIEL will be providing the drug-free treatment to tens of millions of people suffering from heel and foot pain, and plantar fasciitis (painful inflammatory condition of the foot) worldwide.
"The Company intends to build a worldwide brand for drug-free pain relief. On August 26, the Company announced it is continuing its aggressive international expansion in the Republic of Korea, India and Italy, backed by a recent guarantee by the U.S. Government's Export-Import Bank, which will assist the Company in its expansion efforts."
To read the entire report visit: http://www.stockpreacher.com/n/BIEL
See what investors are saying about these stocks at: http://www.stockhideout.com/
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.